Financhill
Back

Omnicell Quote, Financials, Valuation and Earnings

Omnicell Price Quote

$44.99
+0.01 (+1.35%)
(Updated: December 21, 2024 at 5:40 AM ET)

Omnicell Key Stats

Buy
56
Omnicell (OMCL) is a Buy

Day range:
$43.49 - $45.44
52-week range:
$25.12 - $55.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.94
P/B ratio:
1.69%

Volume:
2.6M
Avg. volume:
673.2K
1-year change:
18.59%
Market cap:
$2.1B
Revenue:
$1.1B
EPS:
$-0.39

How Much Does Omnicell Make?

Data Unavailable

Is Omnicell Growing As A Company?

Data Unavailable

Omnicell Stock Price Performance

  • Did Omnicell Stock Go Up Last Month?
    Omnicell share price went up by 7.56% last month
  • Did OMCL's Share Price Rise Over The Last Year?
    OMCL share price rose by 18.59% over the past 1 year

What Is Omnicell 52-Week High & Low?

  • What Is Omnicell’s 52-Week High Share Price?
    Omnicell has traded as high as $55.75 over the past 52 weeks
  • What Is Omnicell’s 52-Week Low Share Price?
    Omnicell has traded as low as $25.12 over the past 52 weeks

Omnicell Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Omnicell?

Data Unavailable

Is Omnicell Cash Flow Positive?

Data Unavailable

Omnicell Return On Invested Capital

Data Unavailable

Omnicell Earnings Date & Stock Price

  • What Is Omnicell's Stock Price Today?
    A single share of OMCL can be purchased today for 44.98
  • What Is Omnicell’s Stock Symbol?
    Omnicell trades on the nasdaq under the ticker symbol: OMCL
  • When Is Omnicell’s Next Earnings Date?
    The next quarterly earnings date for Omnicell is scheduled on February 7, 2025
  • When Is OMCL's next ex-dividend date?
    Omnicell's next ex-dividend date is June 20, 2020
  • How To Buy Omnicell Stock?
    You can buy Omnicell shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Omnicell Competitors

  • Who Are Omnicell's Competitors?
    Below is a list of companies who compete with Omnicell or are related in some way:
    • American Shared Hospital Services (AMS)
    • Astrana Health Inc (ASTH)
    • Cryo-Cell International Inc (CCEL)
    • P3 Health Partners Inc (PIII)
    • 10x Genomics Inc (TXG)

Omnicell Dividend Yield

Data Unavailable

Omnicell Analyst Estimates

YoY Growth Past Surprise
EPS: 58.33% 33.61%
Revenue: -5.44% 0.7%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable